“Comparative study of efficacy of topical anthralin (0.5%) and topical calcipotriol (0.005%) in management of chronic plaque psoriasis” (2023) Journal of Pakistan Association of Dermatologists, 33(3), pp. 827–831. doi:10.66344/jpad.33.3.2023.2195.